Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study.

Jaehyun BaeMin Jung LeeEun Yeong ChoeChang Hee JungHye Jin WangMyoung Soo KimYu Seun KimJoong Yeol ParkEun Seok Kang

Published in: Endocrinology and metabolism (Seoul, Korea) (2016)

Linagliptin demonstrates superior glucose-lowering efficacy and minimal effect on cyclosporine trough levels in comparison with other DPP-4 inhibitors in kidney transplant patients with diabetes.

Keyphrases

blood glucose
metabolic syndrome
blood pressure
oxidative stress
skeletal muscle
weight loss